Navigation Links
Tianyin Pharmaceutical Co., Inc. Announces Trading Symbol Error and Correction
Date:8/20/2008

CHENGDU, China, Aug. 20 /Xinhua-PRNewswire-FirstCall/ -- Tianyin Pharmaceutical, Co., Inc. (OTC Bulletin Board: TYNP, TYNPE), a manufacturer and supplier of modernized traditional Chinese medicine ("TCM") based in Chengdu, China, today announced that the Company's stock symbol had been inadvertently changed to OTC BB: TYNPE due to the electronic eligibility system error.

The error is being corrected immediately and the Company expects the stock symbol to trade under the symbol OTC BB: TYNP on Thursday, August 21, 2008.

Tianyin Pharmaceutical Co., Inc. is a fully-reporting company and the Company's fiscal year ends on June 30. The Company will file its 10K for FY2008 on a timely manner, which is due on September 30. The Company has been compliant is all its fillings.

"This symbol error was very unfortunate and we do wish to assure our shareholders that there is absolutely no problem with Tianyin Pharmaceutical," said Dr. Jiang, Chairman and CEO of Tianyin Pharmaceutical Co., Inc. ''We will announce earnings results for fiscal year 2008 that ended June 30, 2008 before the reporting deadline of September 30, 2008. Additionally, we would like to reiterate that the Company expects to exceed its fiscal year 2008 make good of $5.6 million in net income or fully diluted EPS of $0.16 per share.''

About Tianyin Pharmaceuticals

Tianyin is a manufacturer and supplier of modernized Traditional Chinese Medicine ("TCM") in China. It was established in 1994 and acquired by the current management team in August 2003. It has a comprehensive product portfolio of 34 modernized TCMs in the market, 22 of which are listed in the highly selective National Medicine Catalog of the National Medical Insurance Program. Tianyin owns and operates two GMP manufacturing facilities and an R&D platform supported by leading Chinese academic institutions. The Company has a pipeline of 51 pharmaceutical products pending approval. Tianyin has an extensive nationw
'/>"/>

SOURCE Tianyin Pharmaceuticals
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2

Related medicine news :

1. Viscorp, Inc. Announces Name Change to Tianyin Pharmaceutical Co Inc. and Begins Trading Under the Ticker OTC BB: TYNP
2. Tianyin Pharmaceutical to Present at Roth Third Annual China Discovery Tour in Beijing on May 20, 2008 at 12:40 p.m. Beijing Time
3. Tianyin Pharmaceutical Co., Inc. to Host Fiscal Year 2008 Third Quarter Earnings Conference Call on Thursday, May 15, 2008 at 9:00 a.m. EDT
4. Tianyin Pharmaceutical Co., Inc. Announces Third Quarter 2008 Financial Results
5. Tianyin Pharmaceutical Signs Over 60 New Distribution Agreements with 15 Regional Distributors
6. Tianyin Pharmaceutical Co., Inc. Completes Production for Earthquake
7. Tianyin Pharmaceutical Co., Inc. Receives Chinese SFDA Approval for Simvastatin Tablets
8. Mylan Commences Tender Offers and Consent Solicitations for Its 5.750% Senior Notes Due 2010 and 6.375% Senior Notes Due 2015 in Connection With Its Proposed Acquisition of Mercks Generic Pharmaceutical Business
9. Arena Pharmaceuticals to Present at the NewsMakers in the Biotech Industry Conference
10. Caraco Pharmaceutical Laboratories, Ltd. Announces FDA Approval to Market Generic Version of Zyloprim(R)
11. Schering-Plough/Merck Pharmaceuticals Announce FDA Filing Acceptance of New Drug Application for Loratadine/Montelukast Tablet
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/21/2015)... 21, 2015 On April 2, 2015, ... to Achieve Kylie Jenner Lips With Disastrous ... injured themselves while attempting an at-home lip augmentation ... is that creating an airlock around one’s mouth for ... plump and achieve Kylie Jenner’s now famous pout. (see: ...
(Date:4/21/2015)... April 21, 2015 “ ZeroWire ” ... Tech Report, which takes a look at the latest ... Scott Steinberg, a special reporter for NewsWatch and a ... how ZeroWire is a security system and lifestyle management ... there were over 2 million burglaries in 2010. It ...
(Date:4/21/2015)... Lewisville, TX (PRWEB) April 21, 2015 ... (NYSE:ADPT) announced today it is opening its first freestanding ... located in Chandler, Arizona and will be licensed under ... of the Dignity Health and Adeptus Health joint venture. ... Chandler Regional and Mercy Gilbert Medical Centers said the ...
(Date:4/21/2015)... Wireless Analytics, LLC , a pioneering ... the Boston Business Journal as the 25th fastest-growing private ... a recent event celebrating the 2015 Pacesetters, the ... companies in Massachusetts. , Wireless Analytics was ranked among ... the fastest revenue growth from 2011 through 2014. ...
(Date:4/21/2015)... 2015 The report “Dermatitis ... analysis on the therapeutic development for Dermatitis. ... identifying new targets and MOAs to produce ... TOC is available @ http://www.rnrmarketresearch.com/dermatitis-pipeline-review-h1-2015-market-report.html ... players involved in the therapeutic development for ...
Breaking Medicine News(10 mins):Health News:Celebrity Cosmetic Surgeon Comments on Report of Teen Girls Injuring Themselves Attempting Kylie Jenner-Inspired Twitter Challenge 2Health News:A Leader in Home Security was Featured on NewsWatch Television 2Health News:Dignity Health and Adeptus Health to Open First Freestanding Emergency Room in Chandler, Arizona 2Health News:Dignity Health and Adeptus Health to Open First Freestanding Emergency Room in Chandler, Arizona 3Health News:Wireless Analytics Ranked as 25th Fastest Growing Private Company in Massachusetts 2Health News:Dermatitis Therapeutic Development and Pipeline Market Review H1 2015 Available at RnRMarketResearch.com 2Health News:Dermatitis Therapeutic Development and Pipeline Market Review H1 2015 Available at RnRMarketResearch.com 3Health News:Dermatitis Therapeutic Development and Pipeline Market Review H1 2015 Available at RnRMarketResearch.com 4
... - Health Professionals Calling for Further Guidance From Department ... plastic baby bottles has,been making headlines in North America, ... that 92%(1) of mums are not aware of the ... Us are phasing out,all baby bottles containing Bisphenol-A and ...
... A new report, funded and released by,Avalere Health, showed ... its,CY 2008 Part D Formulary Reference File. In response, ... Medicare offerings in 2008,resulting in significantly smaller Part D ... driven in part to remove hundreds of prescription,drugs that ...
... A large genetic study in mice has identified hundreds of ... DNA of more than 500 lymphomas to find the cancer ... mutations in total, which together implicate almost 350 regions in ... correspond to genes known to be involved in human cancers ...
... focuses on solving real-world problems ... in radiology, ... in radiology and medical image and information management solutions,today announced that its ... at the SIIM 2008,Annual Meeting in Seattle, WA, from May 15 to ...
... Life and Casualty,Company, a national life and health insurer, ... Alzheimer,s Association Rita Hayworth Gala for,their support of the ... "Bankers Life has organized Forget Me Not Days over ... 2003 to support both national and,local efforts," said Harry ...
... the use of pacemakers,implantable cardioverter-defibrillators (ICDs) and ... May 15 The American College,of Cardiology ... Heart Rhythm,Society (HRS) have jointly released updated ... for Device-Based Therapy of,Cardiac Rhythm Abnormalities are ...
Cached Medicine News:Health News:Bounty Poll Reveals British Mums in the Dark Over Bisphenol-A in Baby Bottles 2Health News:Avalere Report Shows Unapproved Prescription Drugs Dropped from CMS Formulary Reference File 2Health News:Avalere Report Shows Unapproved Prescription Drugs Dropped from CMS Formulary Reference File 3Health News:Avalere Report Shows Unapproved Prescription Drugs Dropped from CMS Formulary Reference File 4Health News:Connecting cancer genes 2Health News:AMICAS Focuses on the Future of Radiology IT at SIIM 2008 2Health News:AMICAS Focuses on the Future of Radiology IT at SIIM 2008 3Health News:Bankers Life and Casualty Company Named Corporate Honoree at Alzheimer's Association Chicago Rita Hayworth Gala 2Health News:The American College of Cardiology, American Heart Association and the Heart Rhythm Society Release Updated Cardiac Device-Based Therapy Guidelines 2Health News:The American College of Cardiology, American Heart Association and the Heart Rhythm Society Release Updated Cardiac Device-Based Therapy Guidelines 3Health News:The American College of Cardiology, American Heart Association and the Heart Rhythm Society Release Updated Cardiac Device-Based Therapy Guidelines 4
(Date:4/21/2015)... 2015 Oxfordshire ... more than doubled its overseas sales in just 4 ... winning the Queen,s Award for Enterprise, for Outstanding Achievement ... first HealthScience Communications consultancy, helping its clients bring new ... Having more than doubled its exports in just 4 ...
(Date:4/21/2015)... Cardiologists at Henry Ford Hospital have implanted a device that ... heartbeat. With only handful of hospitals in the ... to add another option to its arsenal of tools for ... to pump. "This is a first in ... at a non-clinical trial site," says cardiologist Claudio Schuger ...
(Date:4/21/2015)...  St. Vincent Healthcare is raising the bar ... strict disinfection routines, St. Vincent Healthcare is now also ... germs, like Ebola, methicillin-resistant Staphylococcus aureus ... patients during their hospital stay. ... http://photos.prnewswire.com/prnh/20150420/199749LOGO ...
Breaking Medicine Technology:Queen's Award Crowns Achievements of Local Consultancy 2Queen's Award Crowns Achievements of Local Consultancy 3Queen's Award Crowns Achievements of Local Consultancy 4Queen's Award Crowns Achievements of Local Consultancy 5Stroke Risk Caused by Abnormal Heart Rhythm Reduced Without Blood Thinners 2Stroke Risk Caused by Abnormal Heart Rhythm Reduced Without Blood Thinners 3St. Vincent Healthcare Deploys Germ-Killing Robot to Prevent Infection, Protect Patients During Hospital Visits 2St. Vincent Healthcare Deploys Germ-Killing Robot to Prevent Infection, Protect Patients During Hospital Visits 3
... Demonstrates Increased Dermal Penetration of TPM/Lidocaine Compared to Topical ... MELBOURNE, Australia, Dec. 8 Phosphagenics Limited ("Phosphagenics") (ASX: POH; ... phase 1 clinical trial that examined the ability of ... the pain relief drug, lidocaine, safely into humans. The ...
... first vaccine candidate for the prevention of RSV , ... Novavax, Inc. (Nasdaq: NVAX ) announced today that ... University of Massachusetts Medical School , will be presenting ... for the prevention of respiratory syncytial virus ("RSV") at the ...
Cached Medicine Technology:Positive Phase 1 Clinical Trial Results for Transdermal Lidocaine 2Positive Phase 1 Clinical Trial Results for Transdermal Lidocaine 3Novavax Announces Preclinical Data for Respiratory Syncytial Virus Vaccine Candidate 2
Lacrimal Cannulas, 19 g. shaft tapering to 23 g. cannula, straight. Overall length 37.5 mm. 5/box....
Anterior Chamber Needle, 27 g., 5 mm from bend to tip. Overall length 22 mm. 5/box....
Anterior Chamber Needle, 25 g. Angled. 9 mm angled tip. Overall length 19 mm. 5/box....
Hydrodissection / Aspiration Cannula, 25 g. Straight with U-tip. U-shaped tip allows aspiration and irrigation at the 12 o'clock position. Overall length 18 mm. 5/box....
Medicine Products: